cycloserine has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, SC; Ho, YJ; Pawlak, CR; Yeh, KY | 1 |
| Chen, FS; Ho, YJ; Pawlak, CR; Wu, FY | 1 |
1 review(s) available for cycloserine and Parkinson Disease
| Article | Year |
|---|---|
Potential of D-cycloserine in the treatment of behavioral and neuroinflammatory disorders in Parkinson's disease and studies that need to be performed before clinical trials.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cycloserine; Humans; Parkinson Disease; Receptors, N-Methyl-D-Aspartate | 2012 |
1 other study(ies) available for cycloserine and Parkinson Disease
| Article | Year |
|---|---|
Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson's disease dementia.
Topics: Animals; Anxiety; Brain; Cycloserine; Dementia; Hippocampus; Image Processing, Computer-Assisted; Immunohistochemistry; Interleukin-2; Male; Maze Learning; Microglia; MPTP Poisoning; Parkinson Disease; Postural Balance; Rats; Rats, Wistar; Recognition, Psychology | 2011 |